Wellcome injects £2 million to turbocharge UK regulation of digital mental health tech

CDSCO, NRAI meets WHO international standards for vaccine regulations

India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI

NPPA brings 80 plus medicines under price regulation

NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.

Eli Lilly seals Centessa acquisition as it bets big on next-gen sleep disorder drugs

Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists

Zydus Lifesciences expands Sri Lanka presence with USD 20 million manufacturing JV

Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience

Experts call for uniform quality standards for blood and blood components

National conference brings together 160+ experts from six states to advance blood quality and safety standards

Health ministry introduces reforms in clinical establishments act to strengthen regulatory efficiency

The amendments notified under the Clinical Establishments Act, 2010 form part of this broader reform initiative aimed at creating a more responsive and facilitative regulatory ecosystem

BioMed X and Biogen launch global neuroimmunology research challenge

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors

AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment

Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)